Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer
We found that the HER2 status of CTC in peripheral blood was inconsistent with the histological findings. Further research should explore the clinical significance of detecting HER2-positive CTCs, and it is desired that real-time HER2 status testing of CTCs could hold potential value for patients with breast cancer.
Authors
- Tianyi Liu (ORCID: https://orcid.org/0009-0006-3733-8859)
- Shijia Wang (ORCID: https://orcid.org/0000-0003-0339-1716)
- Duo Wan
- Wen Zhang (ORCID: https://orcid.org/0000-0001-6631-6209)
- Shulian Wang (ORCID: https://orcid.org/0000-0001-7322-9621)
- Qi Zhang (ORCID: https://orcid.org/0000-0001-9916-8919)
- Xiaoli Zhang (ORCID: https://orcid.org/0000-0001-8837-8558)
- Peipei Xie
- Yuchun Song
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1007/s12672-024-01663-0
- Citations
- 4
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- National Science and Technology Major Project